Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.44 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 6/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 4/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7867806 | 0.97 | P4HTM (0.45) | P4HTMGABRA5NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL7869446 | 0.90 | GABRA5 (0.45) | P4HTMGABRA5NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL7871645 | 0.88 | P4HTM (0.58) | P4HTMGABRA5NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL7871596 | 0.87 | GABRA5 (0.45) | P4HTMGABRA5NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL8869377 | 0.86 | P4HTM (0.56) | P4HTMNPC1RAB9ASMN1; SMN2EPHX2 | |
| SCHEMBL9574661 | 0.86 | GABRA5 (0.51) | GABRA5 | |
| SCHEMBL7869443 | 0.85 | P4HTM (0.43) | P4HTMGABRA5NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL7862856 | 0.84 | HSP90AA1 (0.46) | P4HTMGABRA5NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL9018358 | 0.84 | GABRA5 (0.49) | P4HTMGABRA5NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL7874552 | 0.83 | P4HTM (0.46) | P4HTMGABRA5NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0562512-B1 | Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines | HOECHST AG (DE) | 2001-02-21 | — | — | EP | disclosed |
| EP-0562512-A1 | Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-09-29 | — | — | EP | disclosed |